NCT02543606View on ClinicalTrials.gov

Bioequivalence of Two Formulations of Esomeprazole

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

Esomelone

powder for injection/ infusion Esomeprazole 40mg

DRUG

Nexium

powder for injection/ infusion Esomeprazole 40mg

Trial Locations (1)

40705

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02543606 - Bioequivalence of Two Formulations of Esomeprazole | Biotech Hunter | Biotech Hunter